Superworth

AbbVie PE ratio ABBV

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Nov 3, 2026
49.8×
10-year median
27.9×
Against its 10-year history
74th
percentile: 0 is its lowest day, 100 its highest
10-year range
13.0× to 179×
Peer median
40.8×

AbbVie's PE ratio is 49.8× as of Nov 3, 2026: a share price of $289.50 against $5.81 of earnings per share over the last twelve months.

That is above its ten-year median of 27.9×, higher than on 74% of days in the last ten years.

Over that time it ranged from 13.0× in Mar 2020 to 179× in Nov 2025.

The median for 7 large drugmakers of a similar size is 40.8×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far49.7×49.7×175×
2025174×59.1×179×
202461.8×44.4×69.3×
202342.5×19.4×42.5×
202221.6×19.0×33.8×
202132.2×21.7×41.8×
202022.7×13.0×43.3×
201941.1×16.5×41.1×
201818.8×17.5×36.3×
201723.5×16.2×23.9×
201616.9×16.1×34.8×
201535.1×24.7×63.5×
201429.1×18.1×30.3×

Against its peers

Companies in Drug Manufacturers - General nearest AbbVie's size, closest first, today.

CompanyPE ratio
ABBVAbbVie49.8×
JNJJohnson & Johnson40.9×
MRKMerck150×
AMGNAmgen29.0×
GILDGilead Sciencesn/m
LLYEli Lilly and46.5×
PFEPfizer40.6×
BMYBristol-Myers Squibb14.0×
Peer median40.8×

Where AbbVie ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on AbbVie

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.